Bayer Chief Worried About Innovation, Spanish Debts
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer's chairman, Marijn Dekkers, calls for a greater appreciation of pharmaceutical inventors and brands, as the diversified Big Pharma reported group sales up 4% in 2011, and profits up 90% on lower charges.